HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
批准号:
6172952
负责人:
IRVIN S.Y. CHEN
金额:
$26.09万
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-07-18 至 2003-04-30
关键词:
HeLa cells apoptosis cell cycle cysteine endopeptidases enzyme inhibitors flow cytometry gene mutation human immunodeficiency virus 1 human immunodeficiency virus 2 molecular pathology protein structure function simian immunodeficiency virus site directed mutagenesis tissue /cell culture virus infection mechanism virus protein
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The HIV-1 gene product is a 96 amino acid protein, which is important
for viral replication and likely to be critical for HIV-1 pathogenesis.
Vpr is expressed following infection of cells and is also found packaged
in virions. In 1995, the PI was among the first to describe a novel
phenotype of the Vpr protein whereby cells infected by HIV-1 expressing
Vpr undergo arrest at the G2 phase of the cell cycle. They subsequently
published that cell cycle arrest induced by Vpr is followed by apoptosis
of the arrested cells. Recently, they found that not only does de novo
expression of Vpr induce cell cycle arrest, but Vpr packaged into
virions is capable of inducing cell cycle arrest when introduced into
cells following infection. Vpr has been shown to augment virus
production and one potential function of Vpr is to prevent T-cell clonal
expansion in response to antigens thus suppressing an early step in
establishing an effective immune response. Therefore, Vpr may be a
critical determinant for pathogenic features of HIV-1 disease and
further understanding of Vpr mechanisms of action may facilitate the
development of therapeutic agents directed against Vpr.
Damage to cell DNA by irradiation or chemical modification can lead to
arrest at multiple points in the cell cycle including the so-called G2
checkpoint. Failure to repair the damage can lead to apoptosis.
According to the PI, Vpr is the only gene product known to induce such
an efficient cell cycle arrest in mammalian cells at G2. Thus, an
understanding of the mechanism of action of Vpr will also be important
in understanding the signal transduction pathways which lead to arrest
at the G2 checkpoint in mammalian cells. Previously, the PI generated
a considerable amount of preliminary data about Vpr action, developed
a number of unique assays for assessment of Vpr function and developed
reagents which will allow him to effectively carry forward further
studies on the mechanism of Vpr action. The specific aims are: Aim 1.
To further characterize cell cycle arrest by HIV-1 Vpr. Aim 2. To
further characterize Vpr mediated apoptosis Aim 3. To identify cellular
factors involved in Vpr-mediated cell cycle arrest and apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10160815
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10614634
-
项目类别:
-
资助金额:$18.74万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10468647
-
项目类别:
-
资助金额:$284.77万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10614633
-
项目类别:
-
资助金额:$284.81万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:10160814
-
项目类别:
-
资助金额:$284.79万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
-
批准号:9890819
-
项目类别:
-
资助金额:$287.22万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Administrative Core
-
批准号:10468648
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2020
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10549758
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:10331787
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
In Vivo Gene Editing for HIV-1 Cure
-
批准号:9753575
-
项目类别:
-
资助金额:$67.8万
-
财政年份:2019
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:8899031
-
项目类别:
-
资助金额:$225.61万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9468343
-
项目类别:
-
资助金额:$195.65万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Anti-HIV Gene Therapy: Defend and Attack
-
批准号:9249485
-
项目类别:
-
资助金额:$213.55万
-
财政年份:2015
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Mouse and mathematical models for HIV-1 suppression through HSPC
-
批准号:8915902
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9264595
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:9058597
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8906934
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Gene engineering using CRISPR/Cas9 mutagenesis to eliminate latent HIV-1
-
批准号:8789998
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Survival of the fittest HSPC repopulating clones by anti-HIV-1 gene-modification
-
批准号:8790285
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2014
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
Hematopoietic stem/progenitor cell reservoirs
-
批准号:8659761
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2013
-
负责人:IRVIN S.Y. CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: